Expert Review of Neurotherapeutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 14
Published: March 5, 2025
The
acute
phase
of
secondary
spinal
cord
injury
(SCI)
is
a
crucial
therapeutic
window
to
mitigate
ongoing
damage
and
promote
tissue
repair.
present
systematic
review
critically
evaluates
the
efficacy
safety
current
management
modalities
for
this
phase,
identifying
gaps
in
knowledge
providing
insights
future
research
directions.
In
December
2024,
PubMed,
Web
Science,
Google
Scholar,
Embase
were
accessed
with
no
time
constraints.
All
clinical
studies
investigating
pharmacological
SCI
accessed.
Data
from
3017
patients
(385
women)
collected.
mean
length
follow-up
was
6
±
3.4
months,
age
43.3
10.3
years.
Erythropoietin
(EPO)
improves
motor
function,
reduces
impairment
injury,
modulates
antioxidation
neurogenesis,
minimizes
apoptosis
inflammation.
Although
commonly
administered,
methylprednisolone
shows
uncertain
efficacy.
rho-GTPases
inhibitor
VX-210
levetiracetam
did
not
demonstrate
effectiveness
treatment.
Monosialotetrahexosylganglioside
Sodium
Salt
(GM-1)
riluzole
are
associated
favorable
neurological
outcomes.
Granulocyte
Colony-Stimulating
Factor
(G-CSF)
Hepatocyte
Growth
(HGF)
offer
improved
scores
fewer
side
effects.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(21)
Published: Feb. 3, 2024
Abstract
Spinal
cord
injury
(SCI)
is
a
refractory
neurological
disorder.
Due
to
the
complex
pathological
processes,
especially
secondary
inflammatory
cascade
and
lack
of
intrinsic
regenerative
capacity,
it
difficult
recover
function
after
SCI.
Meanwhile,
simulating
conductive
microenvironment
spinal
reconstructs
electrical
neural
signal
transmission
interrupted
by
SCI
facilitates
repair.
Therefore,
double‐crosslinked
hydrogel
(BP@Hydrogel)
containing
black
phosphorus
nanoplates
(BP)
synthesized.
When
placed
in
rotating
magnetic
field
(RMF),
BP@Hydrogel
can
generate
stable
signals
exhibit
electrogenic
characteristic.
In
vitro,
shows
satisfactory
biocompatibility
alleviate
activation
microglia.
RMF,
enhances
anti‐inflammatory
effects.
wireless
stimulation
promotes
differentiation
stem
cells
(NSCs)
into
neurons,
which
associated
with
PI3K/AKT
pathway.
vivo,
injectable
elicit
behavioral
electrophysiological
recovery
complete
transected
mice
alleviating
inflammation
facilitating
endogenous
NSCs
form
functional
neurons
synapses
under
RMF.
The
present
research
develops
multifunctional
for
repair
targeting
multiple
mechanisms
including
immunoregulation
enhancement
neuronal
differentiation.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
11(8)
Published: Oct. 30, 2023
Microneedles
have
emerged
as
a
promising
platform
for
transdermal
drug
delivery
with
prominent
advantages,
such
enhanced
permeability,
mitigated
pain,
and
improved
patient
adherence.
While
microneedles
primarily
been
employed
delivering
small
molecules,
nucleic
acids,
peptides,
proteins,
recent
researches
demonstrated
their
prospect
in
combination
cell
therapy.
Cell
therapy
involving
administration
or
transplantation
of
living
cells
(e.g.
T
cells,
stem
pancreatic
cells)
has
gained
significant
attention
preclinical
clinical
applications
various
disease
treatments.
However,
the
effectiveness
systemic
may
be
restricted
localized
conditions
like
solid
tumors
skin
disorders
due
to
limited
penetration
accumulation
into
lesions.
In
this
perspective,
an
overview
advances
microneedle-assisted
immunotherapy,
tissue
regeneration,
hormone
modulation,
respect
mechanical
property,
loading
capacity,
well
viability
bioactivity
loaded
is
provided.
Potential
challenges
future
perspectives
microneedle-mediated
are
also
discussed.
Bioactive Materials,
Journal Year:
2024,
Volume and Issue:
39, P. 521 - 543
Published: May 30, 2024
Spinal
cord
injury
(SCI)
often
results
in
irreversible
loss
of
sensory
and
motor
functions,
most
SCIs
are
incurable
with
current
medical
practice.
One
the
hardest
challenges
treating
SCI
is
development
a
dysfunctional
pathological
microenvironment,
which
mainly
comprises
excessive
inflammation,
deposition
inhibitory
molecules,
neurotrophic
factor
deprivation,
glial
scar
formation,
imbalance
vascular
function.
To
overcome
this
challenge,
implantation
functional
biomaterials
at
site
has
been
regarded
as
potential
treatment
for
modulating
microenvironment
to
support
axon
regeneration,
remyelination
site,
recovery
after
SCI.
This
review
summarizes
characteristics
recent
advances
well
technologies
used
modulate
inflammatory
regulate
reshape
revascularization
microenvironment.
Moreover,
technological
limitations,
challenges,
future
prospects
promote
efficient
repair
also
discussed.
will
aid
further
understanding
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(35), P. 8577 - 8604
Published: Jan. 1, 2024
Biosensors
integrated
into
closed-loop
systems
provide
patient-specific
adaptive
therapies.
These
advanced
devices
have
significant
potential
for
managing
chronic
conditions
by
continuously
adjusting
therapeutic
regimens
based
on
physiological
data.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 17, 2024
As
a
transdermal
drug
delivery
method,
microneedles
offer
minimal
invasiveness,
painlessness,
and
precise
in-situ
treatment.
However,
current
rely
on
passive
diffusion,
leading
to
uncontrollable
penetration.
To
overcome
this,
we
developed
pneumatic
microneedle
patch
that
uses
live
Enterobacter
aerogenes
as
microengines
actively
control
delivery.
These
microbes
generate
gas,
driving
drugs
into
deeper
tissues,
with
adjustable
glucose
concentration
allowing
over
the
process.
Our
results
showed
this
microorganism-powered
system
increases
depth
by
200%,
reaching
up
1000
μm
below
skin.
In
psoriasis
animal
model,
technology
effectively
delivered
calcitriol
subcutaneous
offering
rapid
symptom
relief.
This
innovation
addresses
limitations
of
conventional
microneedles,
enhancing
efficiency,
permeability,
introducing
creative
paradigm
for
on-demand
controlled